Media Summary: Mayo Clinic neurologist, Michael Ruff, M.D., explains some of the potential side-effects of Max Topp, MD University of Würzburg, Würzburg, Germany, discusses the importance of training for Robert Hadden, BM BCh, FRCP, PhD, King's College Hospital, London, UK, discusses the predictive markers of patients likely

Neurotoxicity From Car T Cell Therapy Why Does It Happen - Detailed Analysis & Overview

Mayo Clinic neurologist, Michael Ruff, M.D., explains some of the potential side-effects of Max Topp, MD University of Würzburg, Würzburg, Germany, discusses the importance of training for Robert Hadden, BM BCh, FRCP, PhD, King's College Hospital, London, UK, discusses the predictive markers of patients likely The Multiple Myeloma Hub spoke with Peter Forsberg, Colorado Blood Cancer Institute, Denver, US. We asked, In-depth considerations of the toxicities and potential Marion Subklewe, MD, LMU Hospital Munich, Munich, Germany, discusses recognition and

ICANS, or Immune Effector Cell-Associated Anna Sureda, MD, PhD, of the Catalan Institute of Oncology, Barcelona, Spain, outlines the most common side effects that In this live, virtual, interactive event led by Dr. Andrew Srisuwananukorn on October 25, 2025, leading oncologists delivered ... READ THE PAPER: Patients treated with chimeric antigen receptor (

Photo Gallery

Neurotoxicity from CAR T-cell therapy: why does it happen?
CAR-T Cell Therapy: Side-effects and neurotoxicity
Neurotoxicity from CAR T-cell therapy: how can it be managed and who is at risk?
Dealing with CAR T-cell therapy neurotoxicity
What are the side effects of CAR-T cell therapy?
Prediction and causes of neurotoxicity in CAR-T patients
Dr. Sehgal on Managing CRS and Neurotoxicity From CAR T-Cell Therapy
Identifying Signs of Neurotoxicity From CAR T-Cell Therapy
Side Effects of CAR T Cell Therapy
How can neurotoxicity associated with CAR T-cell therapy in MM be managed?
CAR T-Cell Therapy: How Does It Work?
Examining the Toxicities of CAR T-cell Therapy
Sponsored
Sponsored
View Detailed Profile
Neurotoxicity from CAR T-cell therapy: why does it happen?

Neurotoxicity from CAR T-cell therapy: why does it happen?

The Lymphoma Hub are pleased

CAR-T Cell Therapy: Side-effects and neurotoxicity

CAR-T Cell Therapy: Side-effects and neurotoxicity

Mayo Clinic neurologist, Michael Ruff, M.D., explains some of the potential side-effects of

Sponsored
Neurotoxicity from CAR T-cell therapy: how can it be managed and who is at risk?

Neurotoxicity from CAR T-cell therapy: how can it be managed and who is at risk?

The Lymphoma Hub are pleased

Dealing with CAR T-cell therapy neurotoxicity

Dealing with CAR T-cell therapy neurotoxicity

Max Topp, MD University of Würzburg, Würzburg, Germany, discusses the importance of training for

What are the side effects of CAR-T cell therapy?

What are the side effects of CAR-T cell therapy?

CAR

Sponsored
Prediction and causes of neurotoxicity in CAR-T patients

Prediction and causes of neurotoxicity in CAR-T patients

Robert Hadden, BM BCh, FRCP, PhD, King's College Hospital, London, UK, discusses the predictive markers of patients likely

Dr. Sehgal on Managing CRS and Neurotoxicity From CAR T-Cell Therapy

Dr. Sehgal on Managing CRS and Neurotoxicity From CAR T-Cell Therapy

... mAb unless there

Identifying Signs of Neurotoxicity From CAR T-Cell Therapy

Identifying Signs of Neurotoxicity From CAR T-Cell Therapy

While

Side Effects of CAR T Cell Therapy

Side Effects of CAR T Cell Therapy

Watch the full course and our most up-

How can neurotoxicity associated with CAR T-cell therapy in MM be managed?

How can neurotoxicity associated with CAR T-cell therapy in MM be managed?

The Multiple Myeloma Hub spoke with Peter Forsberg, Colorado Blood Cancer Institute, Denver, US. We asked,

CAR T-Cell Therapy: How Does It Work?

CAR T-Cell Therapy: How Does It Work?

CAR T

Examining the Toxicities of CAR T-cell Therapy

Examining the Toxicities of CAR T-cell Therapy

In-depth considerations of the toxicities and potential

CAR T-cell toxicity: CRS, ICANS and prolonged cytopenias

CAR T-cell toxicity: CRS, ICANS and prolonged cytopenias

Marion Subklewe, MD, LMU Hospital Munich, Munich, Germany, discusses recognition and

ICANS (Immune Effector Cell-Associated Neurotoxicity Syndrome) in CAR-T Therapy

ICANS (Immune Effector Cell-Associated Neurotoxicity Syndrome) in CAR-T Therapy

ICANS, or Immune Effector Cell-Associated

CAR-T and neurotoxicity: frequency and management

CAR-T and neurotoxicity: frequency and management

... neurological events that

CAR-T cell therapy neurotoxic complications predicted by Simple blood test

CAR-T cell therapy neurotoxic complications predicted by Simple blood test

CELLTHERAPIES #SIDE EFFECTS According

Side effects of CAR T-cell therapy and their management

Side effects of CAR T-cell therapy and their management

Anna Sureda, MD, PhD, of the Catalan Institute of Oncology, Barcelona, Spain, outlines the most common side effects that

Neurotoxicity of CAR T-Cell Therapy and How Often it Occurs - Blood Cancers OncTalk 2025

Neurotoxicity of CAR T-Cell Therapy and How Often it Occurs - Blood Cancers OncTalk 2025

In this live, virtual, interactive event led by Dr. Andrew Srisuwananukorn on October 25, 2025, leading oncologists delivered ...

Analyzing CAR T-Cell Neurotoxicity in Adult Patients With ALL

Analyzing CAR T-Cell Neurotoxicity in Adult Patients With ALL

The clinical development of

Neurological toxicities associated with chimeric antigen receptor T cell therapy

Neurological toxicities associated with chimeric antigen receptor T cell therapy

READ THE PAPER: http://bit.ly/2Q4y6T1 Patients treated with chimeric antigen receptor (